共 49 条
Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition
被引:102
作者:
Komander, D
Kular, GS
Bain, J
Elliott, M
Alessi, DR
van Aalten, DMF
机构:
[1] Univ Dundee, Div Biol Chem & Mol Microbiol, Sch Life Sci, Dundee DD1 5EH, Scotland
[2] Univ Dundee, MRC Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland
[3] Univ Dundee, Div Signal Transduct Therapy, Sch Life Sci, Dundee DD1 5EH, Scotland
关键词:
7-hydroxystaurosporine (UCN-01);
kinase alignment;
kinase inhibitor specificity;
3-phosphoinositide-dependent protein kinase-1 (PDK1);
CRYSTAL-STRUCTURE;
CATALYTIC SUBUNIT;
STAUROSPORINE;
DOMAIN;
COMPLEX;
PHOSPHORYLATION;
ACTIVATION;
REVEALS;
DENSITY;
SITE;
D O I:
10.1042/BJ20031119
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
PDK1 (3-phosphoinositide-dependent protein kinase-1) is a member of the AGC (cAMP-dependent, cGMP-dependent, protein kinase C) family of protein kinases, and has a key role in insulin and growth-factor signalling through phosphorylation and subsequent activation of a number of other AGC kinase family members, such as protein kinase B. The staurosporine derivative UCN-01 (7-hydroxystaurosporine) has been reported to be a potent inhibitor for PDK1, and is currently undergoing clinical trials for the treatment of cancer. Here, we report the crystal structures of staurosporine and UCN-01 in complex with the kinase domain of PDK1. We show that, although staurosporine and UCN-01 interact with the PDK1 active site in an overall similar manner, the UCN-01 7-hydroxy group, which is not present in staurosporine, generates direct and water-mediated hydrogen bonds with active-site residues. Inhibition data from UCN-01 tested against a panel of 29 different kinases show a different pattern of inhibition compared with staurosporine. We discuss how these differences in inhibition could be attributed to specific interactions with the additional 7-hydroxy group, as well as the size of the 7-hydroxy-group-binding pocket. This information could lead to opportunities for structure-based optimization of PDK1 inhibitors.
引用
收藏
页码:255 / 262
页数:8
相关论文